Intuitive Surgical (NASDAQ:ISRG) EVP Mark Brosius Sells 28 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Mark Brosius sold 28 shares of the firm’s stock in a transaction that occurred on Wednesday, July 29th. The shares were sold at an average price of $360.21, for a total transaction of $10,085.88. Following the completion of the sale, the executive vice president owned 1,322 shares of the company’s stock, valued at approximately $476,197.62. This trade represents a 2.07% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Brosius also recently made the following trade(s):

• On Monday, July 27th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The stock was sold at an average price of $344.00, for a total value of $9,632.00.
• On Friday, June 12th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The shares were sold at an average price of $414.13, for a total value of $10,353.25.
• On Wednesday, June 10th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The stock was sold at an average price of $424.14, for a total value of $9,755.22.
• On Monday, June 8th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The stock was sold at an average price of $420.12, for a total value of $9,662.76.
• On Friday, May 22nd, Mark Brosius sold 18 shares of Intuitive Surgical stock. The stock was sold at an average price of $439.80, for a total value of $7,916.40.
• On Wednesday, May 20th, Mark Brosius sold 18 shares of Intuitive Surgical stock. The shares were sold at an average price of $440.38, for a total value of $7,926.84.
• On Monday, May 18th, Mark Brosius sold 18 shares of Intuitive Surgical stock. The shares were sold at an average price of $422.47, for a total value of $7,604.46.

Intuitive Surgical Price Performance

NASDAQ ISRG traded down $8.70 during trading on Wednesday, hitting $353.10. The company’s stock had a trading volume of 2,734,251 shares, compared to its average volume of 2,426,992. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The company has a market cap of $124.74 billion, a PE ratio of 40.45, a P/E/G ratio of 2.58 and a beta of 1.46. The business’s 50 day simple moving average is $403.62 and its 200-day simple moving average is $455.95.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.48 by $0.32. The firm had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The company’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.81 earnings per share. Analysts expect that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds have recently added to or reduced their stakes in ISRG. Draper Asset Management LLC boosted its position in Intuitive Surgical by 41.9% during the fourth quarter. Draper Asset Management LLC now owns 5,029 shares of the medical equipment provider’s stock worth $2,848,000 after purchasing an additional 1,485 shares in the last quarter. Deutsche Bank AG increased its position in shares of Intuitive Surgical by 9.6% in the fourth quarter. Deutsche Bank AG now owns 1,522,191 shares of the medical equipment provider’s stock valued at $862,108,000 after buying an additional 132,966 shares in the last quarter. Oppenheimer Asset Management Inc. raised its stake in shares of Intuitive Surgical by 29.3% during the 4th quarter. Oppenheimer Asset Management Inc. now owns 71,077 shares of the medical equipment provider’s stock worth $40,255,000 after buying an additional 16,119 shares during the period. Robinhood Asset Management LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter worth approximately $6,478,000. Finally, KBC Group NV lifted its position in shares of Intuitive Surgical by 4.7% during the 4th quarter. KBC Group NV now owns 420,593 shares of the medical equipment provider’s stock valued at $238,207,000 after buying an additional 18,697 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. Stifel Nicolaus decreased their price target on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a report on Friday, July 17th. Barclays set a $651.00 price objective on shares of Intuitive Surgical and gave the company an “overweight” rating in a report on Thursday, April 23rd. Wells Fargo & Company restated an “overweight” rating and issued a $487.00 target price (down from $654.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. Evercore set a $430.00 price target on Intuitive Surgical in a research report on Monday, July 6th. Finally, Royal Bank Of Canada dropped their price target on Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating on the stock in a research note on Monday, July 13th. Twenty-one investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $517.21.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.